Q&A: How pharma partnerships could benefit digital therapeutics companies

Q&A: How pharma partnerships could benefit digital therapeutics companies

Austin Speier, chief strategy officer at Click Therapeutics, discusses the company’s expanded partnership with Boehringer Ingelheim.

Austin Speier, chief strategy officer at Click Therapeutics, discusses the company’s expanded partnership with Boehringer Ingelheim.


Go to Source
2023-02-03 21:45

Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.

Author: admin